Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
09/26/2002 | US20020137096 Solid phase synthesis; photolithography |
09/26/2002 | US20020137085 Multiplexed generation of chemical or physical events |
09/26/2002 | US20020137079 Analyzing polynucleotide sampling |
09/26/2002 | US20020137074 Selectivity of nucleic acid diagnostic and microarray technologies by control of interfacial nucleic acid film chemistry |
09/26/2002 | US20020137072 Nanoparticles having oligonucleotides attached thereto and uses therefor |
09/26/2002 | US20020137071 Nanoparticles having oligonucleotides attached thereto and uses therefor |
09/26/2002 | US20020137070 Colorimetric analysis |
09/26/2002 | US20020137058 Nanoparticles having oligonucleotides attached thereto and uses therefor |
09/26/2002 | US20020137057 Detecting genes in biological sample; detector libraries |
09/26/2002 | US20020137045 Attachment of oligonucleotides to solid supports through schiff base type linkages for capture and detection of nucleic acids |
09/26/2002 | US20020136978 Transfer of arrayed chemical compositions |
09/26/2002 | US20020136761 Ribonucleotide-oligonucleotide with a specific sequence that binds to both the negative and positive strands of influenza RNA |
09/26/2002 | CA2441564A1 Production of pancreatic islet cells and delivery of insulin |
09/26/2002 | CA2441086A1 Identification of gene expression alterations underlying the aging process in mammals |
09/26/2002 | CA2441021A1 Method for alteration detection |
09/26/2002 | CA2435664A1 Ncc2705-the genome of a bifidobacterium |
09/26/2002 | CA2425902A1 Urocortin-iii and uses thereof |
09/25/2002 | EP1243661A1 Method for reverse transcription |
09/25/2002 | EP1243659A1 Method for detecting target nucleotide sequences |
09/25/2002 | EP1243597A2 Receptors for human interleukin-12 |
09/25/2002 | EP1242631A1 Multispecies food testing and characterization |
09/25/2002 | EP1242611A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
09/25/2002 | EP1242177A1 Method and device for the mask-free production of biopolymers by means of a light diode array |
09/25/2002 | EP1175432A4 Processes for the synthesis of oligomers using phosphoramidite compositions |
09/25/2002 | EP0912470B9 Method and device for purifying and enriching molecules |
09/25/2002 | EP0751948B1 Novel phosphoramidate and phophorothioamidate oligomeric compounds |
09/25/2002 | CN1371356A Enatiomerically-enriched compounds having photocleavable bond(s) and methods related thereto |
09/25/2002 | CN1371303A Method and device for performing operations at charged microlocations |
09/25/2002 | CN1370779A Nucleotide extracting process from waste gourmet powder material |
09/24/2002 | US6455754 Screening for modulators of neuronal receptor binding activity; obtain animal model, incubate with modulator, monitor adjustments in neuronal activity |
09/24/2002 | US6455689 Antisense-oligonucleotides for transforming growth factor-β (TGF-β) |
09/24/2002 | US6455682 Polyamide compound for use in determining the sequence of a target polynucleotide |
09/24/2002 | US6455674 Polypeptide for use in the diagnosis and treatment of tissue oxygenation defects |
09/24/2002 | US6455673 Polypeptide for use as vaccine in prevention of microorganismal infections |
09/24/2002 | US6455267 Methods and kits useful for determining the status of and detecting pancreatic B-cell associated autoimmune diseases |
09/24/2002 | US6455258 Contacting nucleic acid sample from skin tumor cells with probe which binds selectively to chromosomal regions that show altered copy number; accurate diagnosis |
09/24/2002 | US6455255 Using selectively primed adaptive driver-representational difference analysis |
09/24/2002 | US6455245 For immunoassay detection |
09/19/2002 | WO2002072888A2 Polymorphisms in the human cmoat gene and uses thereof |
09/19/2002 | WO2002072883A2 Nucleotide carrier for diagnosing and treating oral diseases |
09/19/2002 | WO2002072832A2 Therapeutic binding molecules |
09/19/2002 | WO2002072831A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
09/19/2002 | WO2002072825A2 Human mrp5-like protein |
09/19/2002 | WO2002072791A2 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid support |
09/19/2002 | WO2002072772A2 Methods and compositions for amplification of rna sequences |
09/19/2002 | WO2002072140A2 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro |
09/19/2002 | WO2002057481A3 Repeat-free probes for molecular cytogenetics |
09/19/2002 | WO2002022631A3 Regulation of human pyroglutamyl peptidase-like enzyme |
09/19/2002 | WO2001090185A3 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof |
09/19/2002 | WO2001046462A3 Methods for the detection, quantification and differentiation of infectious versus non-infectious pathogens in a sample |
09/19/2002 | US20020133847 Plant proteins |
09/19/2002 | US20020133836 Methods to identify swine genetically resistant to F18 E. coli associated diseases |
09/19/2002 | US20020133000 Neuronal protein for use in inducing sleep and for treatment of sleep disorders |
09/19/2002 | US20020132995 Modulation of immune response to preferential nucleotide sequences; obtain nucleotide sequence sample, insert adjusted nucleotides, administer to mammals monitor immune response |
09/19/2002 | US20020132981 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
09/19/2002 | US20020132775 Human potassium channel 1 and 2 proteins |
09/19/2002 | US20020132768 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
09/19/2002 | US20020132767 Nucleic acids, proteins, and antibodies |
09/19/2002 | US20020132753 Nucleic acids, proteins, and antibodies |
09/19/2002 | US20020132347 Genetically engineered cell for use in the diagnosis, prevntion and treatment of viral diseases |
09/19/2002 | US20020132334 Nucleotide sequences coding preferential polypeptide for use in the treatment of tumors and nervous system disorders |
09/19/2002 | US20020132264 Solid support for evaluating preferential biopolymers in sample |
09/19/2002 | US20020132263 Enzyme detection/assay method and substrates |
09/19/2002 | US20020132254 Molecular labeling and assay systems using poly (amino acid)-metal ion complexes as linkers |
09/19/2002 | US20020132253 Nucleotide sequences coding membrane protein for use in diagnosis and treatment of athersclerosis, infections, arthritis, cancer, kidney and nervous system disorders |
09/19/2002 | US20020132252 Nucleotide sequences coding membrane protein for use in the diagnosis and treatment of infections, arthritis, nervous system and kidney disorders, cancer and atherosclerosis |
09/19/2002 | US20020132251 Detecting mutation in target nucleotide sequences; obtain sample, incubate with peptide nucleic acids, degrade single stranded nucleotide sequences, detect mutation in target nucleotide sequences, degradation products indicate mutation |
09/19/2002 | US20020132242 Nucleic acid archiving |
09/19/2002 | US20020132241 Detecting preferential particles in sample; obtain sample, incubate with primers, amplify, detect amplicons, presence of amplicons indicates the presence of target particle |
09/19/2002 | US20020132240 Nucleotide sequences coding membrane proteins for use in treatment of cancer, infections, cardiavascular, nervous system, skin and kidney disorders |
09/19/2002 | CA2692552A1 Novel protein isolated from pleurotus cornucopiae |
09/19/2002 | CA2443557A1 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid support |
09/19/2002 | CA2439188A1 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro |
09/19/2002 | CA2437963A1 Therapeutic binding molecules |
09/19/2002 | CA2435998A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
09/18/2002 | EP1240322A2 Therapeutic uses of lna-modified oligonucleotides |
09/18/2002 | EP1240312A2 Plant gene |
09/18/2002 | EP1240178A2 Methods and materials relating to prothrombinase-like polypeptides and polynucleotides |
09/18/2002 | EP1212339A4 2'-o-acetamido modified monomers and oligomers |
09/18/2002 | EP1180113A4 Oligonucleotides having a-dna form and b-dna form conformational geometry |
09/18/2002 | EP1088095A4 Novel molecules of the t110-related protein family and uses thereof |
09/18/2002 | EP0764217B1 Use of a specific marker for detecting Salmonella with PCR |
09/18/2002 | EP0693936B1 Cloned leptospira outer membrane protein |
09/18/2002 | EP0630249B1 Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof |
09/18/2002 | CN1369506A Human Protein for promoting transform of 3T3 cell and its coding sequence |
09/18/2002 | CN1369505A Human protein for promoting transform of 3T3 cell and its coding sequence |
09/18/2002 | CN1369503A Gene for controling transform of mouseearcress from monocyclic flower to polycyclic flower |
09/18/2002 | CN1369502A Specific gene for controlling thickness of moaseearcress' stem |
09/18/2002 | CN1369501A Gene of 26S proteinase alpha subunit for regulating degradation of mouseearcress' abnormal protein |
09/18/2002 | CN1091111C Structure and usage of antisense oligonucleotide for treating diseases correlative to hepatitis C virus |
09/17/2002 | WO2001070751A1 Reactive monomers for the oligonucleotide and polynucleotide synthesis, modified oligonucleotides and polynucleotides, and a method for producing the same |
09/17/2002 | US6453243 Method for displaying result of hybridization experiment using biochip and method for evaluating experimental error of hybridization experiment |
09/17/2002 | US6452066 GENOMIC DNA FRAGMENTS CONTAINING REGULATORY AND CODING SEQUENCES FOR THE β2-SUBUNIT OF THE NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR AND TRANSGENIC ANIMALS MADE USING THESE FRAGMENTS OR MUTATED FRAGMENTS |
09/17/2002 | US6451998 Capping and de-capping during oligonucleotide synthesis |
09/17/2002 | US6451991 Nuclease resistance, medical diagnosis; oligonucleotides comprising nucleosides having phosphorothioate linkages |
09/17/2002 | US6451968 Hoogsteen type base pairing in triplex motif; diagnosis; heat resistance; detection of point mutations, restriction enzyme sites, and transcription inhibition |
09/17/2002 | US6451573 Proteinase inhibitor, precursor thereof and genetic sequences encoding same |
09/17/2002 | US6451559 Expression vector for improved production of polypeptides in yeast |
09/17/2002 | US6451554 Purified nucleic acid sequence encoding a sodium channel protein wherein said nucleic acid sequence comprises the coding portion of the nucleic acid sequence and producing a mammalian sensory neuron sodium channel protein, wherein the |
09/17/2002 | US6451546 Plant glurs of the invention may function as signal transducers involved in the regulation of plant growth. the invention also relates to the identification of compounds that modulate the activity of the plant glur and herbicides |